Normal numbers of circulating B lymphocytes are reached during the first 6 months following allogeneic BMT, but humoral immunity remains poor. The molecular basis for this lack of function in the first appearing B lymphocytes has not been clarified. Accordingly, we have studied the reconstitution of the VH3 containing Ig repertoire in two CML patients transplanted with allogeneic BM and one healthy control. PBMCs were isolated at several time-points after BMT and mRNA was prepared. VH3 containing Ig rearrangements were amplified with RT-PCR and then cloned and analyzed with colony hybridization using complementary determining region 3 (CDR3)-specific oligonucleotide probes. Four weeks after BMT, two individual clones together represented 52% of the analyzed CDR3 regions. At 6, 8 and 12 weeks after BMT the corresponding probes hybridized with 2-6% of the colonies. A similar pattern was obtained for the other patient. In samples from the healthy control no clones were detected using CDR3-specific oligonucleotide probes from the control. We conclude that the VH3 containing Ig repertoire after BMT is oligoclonal and that specific rearrangements dominate at different time-points. This restriction of the B cell repertoire may contribute to the impaired humoral immunity observed in BMT recipients.
due to the similarities with the ontogenic development of the B lymphocyte compartment, ie a similar immature phenotype and function of post-transplant and cord blood B cells. 8 Furthermore, the post-BMT immune deficiency may be explained by a restricted usage of the Ig genes, as seen in fetal and neonatal life. [9] [10] [11] The genes encoding the variable and constant region of the Ig heavy chain (IgH) are located on chromosome 14q. Variability in the antigen binding site is obtained by recombination of one diversity (D) gene to one junctional (JH) gene, and a second recombination of this complex to a variable (VH) gene segment. 12, 13 Additional diversity of the Ig repertoire is created by addition of nucleotides in the junctions between the VH, D and JH gene segments, 14, 15 combination of the intracellular IgH protein with a or light chain, and somatic mutations. 16 The most variable part of the heavy chain is the CDR3 region which is formed by the junctions between the gene segments.
The human VH genes are divided into seven families based on nucleotide sequence homology. 17 The largest family is VH3, which contains 28 gene segments with an open reading frame and the smallest is VH6, with one functional gene. 18 Analysis of VH gene family usage in BMT patients shows that VH3 utilization is decreased two-to three-fold 30-90 days post BMT, compared to normal adults, and is compensated for by transient overexpression of VH4, VH5 and VH6. 19 Usage of the VH3 genes that characterize the fetal repertoire, 56p1 and 20p1, is increased two orders of magnitude 2-5 months post transplantion. 20 At 21 months after BMT the percentage of B cells that express these genes is still two-to six-fold higher compared with healthy adults. 20 In contrast to these findings, Suzuki et al 21 reported a pattern of usage of VH3 and VH4 genes in patients, at 90 days and 1 year after BMT, that is similar to the pattern in healthy adults. However, they show a lack of somatic mutations in Ig gene rearrangements from patients that is consistent with a defect in antigen-driven B cell responses. 21 In a detailed nucleotide sequence analysis of VH6 containing Ig gene rearrangements in peripheral B cells at different time-points after BMT we have shown that the repertoire is very restricted from 4 weeks to 3 months post BMT. In addition, diversification of the repertoire appeared to follow a wave-like pattern with different rearrangements dominating at different time-points. 22 In the present work we have designed CDR3-specific oligonucleotide probes for clone frequency determination of VH3 containing rearrangements. This new approach of repertoire analysis made it possible for us to analyze a large number of Ig rearrangements at different time-points after BMT. The dominance of the VH3 gene family in the peripheral Ig repertoire, in combination with an extended sample material, allows us to conclude that the Ig repertoire, irrespective of VH gene usage, is oligoclonal during reconstitution after BMT.
Materials and methods

Patients and donors
Peripheral blood samples were, after informed consent, derived from two BM recipients and one healthy control (ethical permission 21/78 from the Ethical Committee at Huddinge University Hospital). All three individuals were 39-year-old Caucasian men. Both patients were treated for CML. The patients received non-modified BM, patient 1 from an HLA-identical sibling donor and patient 2 from an HLA-identical matched unrelated donor (MUD). Patient 1 was in complete first chronic phase at the time of transplantation. Patient 2 was partially in chronic phase with 13% myeloblasts in the BM 1 week before transplantation. Conditioning regimen was cyclophosphamide and TBI, with addition of antithymocyte globulin in patient 2. Both patients were given MTX and CsA as GVHD prophylaxis. Details regarding the treatment have been published previously. 23 
Isolation of mononuclear cells
PBMC were obtained from peripheral blood by gradient separation on lymphoprep (Nycomed-Pharma AS, Oslo, Norway). The PBMC were washed twice in PBS and resuspended in 0.1 ml solution D (4 mol/l guanidinium thiocyanate, 25 mmol/l sodium citrate pH 7.0, 0.5% laurylsarcosyl and 0.1 mol/l 2-mercaptoethanol) per 10 6 cells. The resuspended PBMC were frozen at −80°C until RNA preparation was performed.
Extraction of total RNA
Total RNA was isolated by acid guanidinium thiocyanatephenol-chloroform extraction as previously been described. 24 In brief, the cells resuspended in solution D were thawed on ice, proteins were extracted with acidic phenol and total RNA was recovered from the aqueous phase by isopropanol precipitation. The pellet was dissolved in DEPC (diethyl pyrocarbonate)-treated H 2 O. The concentration and purity of the preparation were determined by measuring the absorbance at 260 and 280 nm (DU-62 Spectrophotometer; Beckman Instruments, Fullerton, CA, USA). Between 2 and 26 g of RNA was isolated from each PBMC sample. The integrity of the RNA was confirmed on a 1% agarose gel.
Isolation of mRNA and first-strand cDNA synthesis
The whole sample of total RNA from each time-point was used for isolation of mRNA with the PolyATract mRNA isolation System III (Promega, Madison, WI, USA). The mRNA isolation kit takes advantage of streptavidin-labeled magnetic particles and biotinylated oligonucleotide (dT) probes. The procedure was performed according to the instructions from the manufacturer. The isolated mRNA fraction was desiccated under vacuum and the mRNA was dissolved in 16 l DEPC-treated H 2 O. For cDNA synthesis 8 l of the mRNA preparation was used. The synthesis was performed with the First-Strand cDNA Synthesis Kit (Pharmacia Biotech, Uppsala, Sweden) according to recommendations from the manufacturer.
PCR and PCR primers
PCR was performed in a total volume of 50 l 1 × PCR buffer (50 mmol/l KCl, 10 mmol/l Tris-HCl pH 8.3, 1.5 mmol/l MgCl 2 , 0.001% gelatin) containing 3.0 l cDNA reaction, 0.2 mmol/l dNTPs, 0.5 mol/l of the VH3 primer, 0.33 mol/l of the JH1, 2, 4,5 primer, 0.08 mol/l of the JH3 primer, 0.08 mol/l of the JH6 primer, 10% glycerol and 2.5 U AmpliTaq (Perkin Elmer, Roche Molecular Systems, Branchburg, NJ, USA). The PCR was performed using a thermal cycler (Techne Ltd, Cambridge, UK) with a cycling program as follows: pre-heating 1 min at 95°C; 1 min at 95°C, 1 min at 63°C and 1 min at 72°C for 15 cycles (63°C to 72°C Rate 15°C/min.); 1 min at 95°C, 1 min at 58°C and 1 min at 72°C for 25 cycles (58°C to 72°C Rate 30°C/min.) and finally an elongation step 10 min at 72°C. The following PCR primers were used:
VH3: 5′-GGGCGGCCGCTCCTGTGCAGCCTCTGGATTT-3′ JH1,2,4,5: 5′-CCCTCGAGAGGAGACGGTGACCAGGGT-3′ JH3: 5′-CCCTCGAGGAAGAGACGGTGACCATTGT-3′ JH6: 5′-CCCTCGAGAGGAGACGGTGACCGTGGT-3′
Restriction sites (NotI for VH3 and XhoI for JH primers) are underlined.
Cloning and DNA sequencing
The amplified PCR products were cut with the restriction enzymes NotI and XhoI (Amersham, Buckinghamshire, UK) and thereafter subcloned into the NotI-XhoI sites of the pBluescript II KS − vector (Stratagene, La Jolla, CA, USA). The constructs were used to transform Nova blue E. coli (Novagen, Madison, WI, USA). Plasmid preparations from 12 bacterial clones from each time-point were used for double-stranded DNA sequencing which was performed with a Sequenase Version 2.0 DNA Sequencing Kit as recommended by the manufacturer (United States Biochemical, Cleveland, OH, USA). The sequence reactions were separated on a denaturing 6% acrylamide gel and detected with autoradiography.
Design of CDR3-specific oligonucleotide probes
DNA sequences obtained at the different time-points from patients and control served as templates for design of the CDR3-specific olignucleotide probes ( Figure 1 ). Sequence data were analyzed with GCG package (HGMP Resource Centre, Harrow, UK) software Fasta to identify the VH3, D and JH genes. The criteria for identification have previously been described in detail. 22 Sequences from each time-point were also aligned using Lasergene, MegAligne (DNASTAR, Madison, WI, USA) to identify clones with identical sequences. These repeats were, when present, preferentially used as templates for the olignucleotide probes. The aim was to make the individual probes as specific as possible for each CDR3 region with as little overlap as possible with the intact part of the three gene segments.
Hybridization to PCR-amplified cDNA libraries
The subcloned PCR products from above were again used for transformation. Approximately 500 colonies from each time-point in the patients and 1000 colonies from each time-point in the control were picked to fresh LA plates. One replica filter for each probe was prepared using Hybond-N+ nylon membranes (Amersham). After alkaline denaturation and UV cross-linking of the DNA, the filters were hybridized with the CDR3-specific oligonucleotide probes and a JHC probe (Figure 1 ). 25 Pre-hybridization was performed in 6 × SSC (20 × SSC: 3 mol/l NaCl, 0.3 mol/l Na citrate, pH 7.0), 10 × Denhardt's (0.2% w/v Ficoll, 0.2% w/v polyvinyl pyrrolidone, 0.2% w/v BSA), 1% SDS and 100 g/l boiled herring sperm DNA at 55°C. After prehybridization the denatured 32 P-labeled olignucleotide probes were added and the filters were hybridized at 55°C overnight. The oligonucleotide probes were 32 P-labeled with Terminal deoxynucleotidyl transferase (Promega) according to instructions from the manufacturer. After hybridization the filters were washed twice in 0.1 × SSC, 1% SDS for 20 min at room temperature (RT). The JHC probe consists of a mixture of four different oligonucleotides derived from the sequences of JH2, JH3, JH4 and JH6 genes. 25 To ensure that the JH4 olignucleotide also hybridized to JH1 and JH5 gene sequences, the hybridization was performed at 35°C and the filters were washed at lower stringency, ie 1 × SSC, 1% SDS at RT.
Statistical analysis of CDR3-positive colonies
Statistical analysis of the numbers of positive colonies in Table 3 Figure 2 , we also used Yates corrected 2 test. The maximum value for each oligonucleotide probe was compared with the value for the same probe at the time-points immediately before and after the timepoint for the maximum value. In this case, 14 different comparisons were made and an overall P Ͻ 0.05 requires ␣ Ͻ 0.004, P Ͻ 0.01 requires ␣ Ͻ 0.0007 and P Ͻ 0.001 requires ␣ Ͻ 0.00007. 
Results
Reconstitution of WBC and soluble Ig after BMT
Both patients 1 and 2 had normal levels of serum Ig before BMT, except for IgG in patient 2 that was somewhat low (Table 1 ). Patient 1 also had a normal level of WBC, but in patient 2 the numbers were elevated. In patient 1 the serum Ig levels were still normal at 4 weeks after BMT, but decreased and were still below normal levels at 8 months after transplantation. In patient 2 serum IgM was at the lower limit of the normal range at 2.5 weeks after BMT and serum IgG was below normal. At 6 months post BMT serum IgG was still low, but the IgM level was within the normal range. The total WBC counts were within the normal range for all time-points tested after BMT in both patients. WBC counts and Ig levels were normal for the control (data not shown).
Nucleotide sequence analysis of VH3 containing rearrangements
In patient 1 a total of 51 sequenced clones, in patient 2 40 clones and in the control 37 VH3-positive clones were analyzed for D and JH gene usage. The D gene usage varied, but D2 and DN1 were the most frequently used D genes in both patient 1 and patient 2. DN1 was also frequently used in the control, but the most frequently used D gene was DXP1. The JH gene usage was dominated by JH4b and JH6b ( Figure 1 and data not shown), in agreement with our previously published results. 22 Many of the sequenced clones originating from the same time-point had an identical sequence, ie they represent the same rearrangement event. One rearrangement was identified at more than one time-point. This rearrangement was first identified as clone 33 from 6 weeks after BMT in patient 1 ( Figure 1 ) and was later identified in the same patient at 8 weeks after BMT as clone 4 (sequence not shown). 
Specificity of the oligoncleotide probes
The specificity of all CDR3-specific oligonucleotide probes in patient 2 and one of the probes in patient 1 was tested by hybridization with the cloned PCR fragments originally used for DNA sequence analysis. The results are presented in Table 2 . Probe 1 recognizes the corresponding CDR3 region with high specificity and does not cross-hybridize with a clone from the control. Both clones were positive with the JHC probe. In patient 2 probes 7, 8 and 9 gave a strong hybridization signal with each corresponding clone and probe 10 gave a medium signal. Probe 9 shows a slight cross-reactivity with the other clones and also with the plasmid alone. All clones, except the negative plasmid control, were positive with the JHC probe.
Restriction of the Ig repertoire in BM recipients
In Table 3 we present data from hybridization of the CDR3-specific oligonucleotide probes with PCR-amplified cDNA clones from different time-points after BMT in patient 1, patient 2 and the healthy control. In patient 1 the Ig repertoire at 4 weeks post BMT was very restricted, 260 out of 496 colonies (52%) were recognized by two individual oligonucleotide probes (Table 3 ). These two probes were designed using two rearrangements originally identified at 4 weeks post BMT as templates (Figure 1 ). To a lesser degree, but still with high significance (P Ͻ 0.01) compared to the control, CDR3-specific probes 3, 4 and 5 hybridized with colonies from the time-points corresponding to when the rearrangement was first identified ( Table 3 ). The individual CDR3 regions recognized by probes 1, 2, 3 and 5 were also present at other time-points after BMT although in much lower frequency. Probe 6 recognizes 10 out of 496 colonies (P Ͻ 0.01) in the sample from 4 weeks after BMT (Table 3 ), but no colonies at any other time-point even though this oligonucleotide probe was designed based upon a sequence first isolated at 7 months after BMT. A similar pattern of hybridization was seen in patient 2 using CDR3-specific oligonucleotide probes 7, 8 and 9 (Table 3) . Oligonucleotide probe 7 hybridized with 11 out of 468 colonies (P Ͻ 0.01), probe 8 hybridized with five out of 478 (NS) and probe 9 hybridized with 40 out of 501 colonies (P Ͻ 0.01) at the time-points corresponding to when the rearrangements were first identified. Oligonucleotide probe 10 did not hybridize with any colonies in samples from Table 2 Hybridization controls for oligonucleotide probe specificity (Table 3 ). In the control no positive colonies could be identified using any of the CDR3-specific probes, although approximately 1000 colonies were positive with the JHC oligonucleotide probe at each time-point (Table 3) .
Kinetics of reconstitution of individual rearrangements after BMT
In Figure 2 we show the kinetics of the frequency of expression of the individual CDR3 regions identified in patient 1 and 2. In patient 1, the rearrangements identified by probe 1 and 2 were dominant 4 weeks after BMT, with a representation of nearly 30% (P Ͻ0.001) of all colonies for each CDR3 sequence (Figure 2a) . The cloned Ig rearrangements that served as templates for these probes were first identified at this time-point (Figure 1 ). Probes 3, 4 and 5 also identified their corresponding CDR3 regions with highest frequency at the time-points when the original isolation was made. Probe 4 recognized 6% of the rearrangements at 8 weeks post BMT (P Ͻ 0.001) (Figure 2a ). The CDR3 regions recognized by probes 1, 2, 3 and 5 were detected at more than one time-point. Probe 6 recognized a sequence first isolated at 7 months after BMT, but this rearrangement was only found 4 weeks post BMT when screening the replica filters ( Figure 2a ) at a frequency of 2% (NS). In patient 2 the most dominant rearrangement at any time-point was recognized by probe 9 at 8 weeks after BMT (Figure 2b ). The frequency of this CDR3 region among all JHC-positive colonies was 8% (P Ͻ 0.001), and it was first identified at 8 weeks after BMT. Probe 9 also recognized the corresponding rearrangement at 6 months post BMT at a frequency of 1.6% (NS). Probe 7 and 8 isolated at 4 and 6 weeks post BMT, respectively, only recognized their corresponding CDR3 region at these time-points. The frequency of these rearrangements is 2.4% (P Ͻ 0.05) and 1.0%, respectively (NS). Probe 10, corresponding to a rearrangement first isolated 6 months after BMT, did not hybridize to any CDR3 region at any time-point (Figure 2b) .
Discussion
In the present work we show that the VH3 containing Ig repertoire is oligoclonal in patients post BMT compared to a healthy control ( Table 3 ), and that different clones appear to dominate at different time-points (Figure 2 ). In the two patients studied 1.6-27% of the approximately 500 JHCpositive colonies screened from each PCR-amplified cDNA library were significantly (P Ͻ 0.05) positive with the corresponding CDR3-specific oligonucleotide probes. In the healthy control none of approximately 1000 JHC-positive colonies hybridized to the control-derived CDR3-specific probes. This is expected due to the enormous diversity of a normal peripheral antibody repertoire and indicates that a CDR3 hybridization frequency of 1.6% represents a striking restriction of repertoire diversity in the patients.
We have previously shown that diversification of the VH6 containing Ig repertoire is oligoclonal following allogeneic BMT and that development of the repertoire follows a wave-like pattern. 22 Although the VH6 gene family is over-represented in the peripheral Ig heavy chain repertoire after BMT, compared with the repertoire in normal adults, 19, 20 it is still a relatively small family and we could not draw general conclusions about Ig repertoire reconstitution. The VH3 gene family is, however, represented in 50-60% of the peripheral B cell repertoire in healthy adults 26, 27 and in 20-40% of the repertoire up to 3 months post BMT. 19 Taken together, our analyses suggest that oligoclonality is a general property of Ig repertoire reconstitution following allogeneic BMT.
A limitation in our previous study of the VH6 containing Ig repertoire was that a limited number of PCR clones were sequenced from each patient and time-point after BMT. To circumvent this problem, we have in the present study, developed a new approach with the advantage of higher sensitivity, ie increased possibilities to detect rare rearrangements. From these experiments we conclude that different clones have a dominant peak at different timepoints post BMT (Figure 2) . However, the CDR3-specific oligonucleotide probes detect positive clones also at other time-points, but at lower frequency, showing that the B cell clones do not disappear from the repertoire ( Table 3) . The most striking example of this is the result with probe 6, where the original sequence was isolated from patient 1 at 7 months after BMT. Probe 6 only detected this rearrangement in the sample from 4 weeks post BMT ( Table 3 ), implying that this clone was present in the repertoire of patient 1 from 4 weeks to 7 months after BMT, but probably at a low frequency.
Our results raise two main questions: first, what is the etiology of the limited Ig repertoire and second, does the restriction of the Ig repertoire at the molecular level result in functional consequences in the form of a limited number of specificities among circulating antibodies? One explanation for the oligoclonal appearance of the VH3 containing Ig repertoire post BMT may be immunosuppressive treatment. CsA directly inhibits B cell proliferation in response to B cell receptor cross-linking, 28 but the major effect of CsA is inhibition of T H activation and cytokine production that indirectly may affect the B cell response. 29 
BMT recipients have a restricted CD4
+ and CD8 + T cell repertoire, possibly due to an impaired thymus function in adult recipients. The reduced function of the thymus leads to reconstitution of T cell numbers via peripheral expansion of mature T cells in the graft as well as mature T cells of recipient origin that have survived the preconditioning. [30] [31] [32] Previous work has demonstrated clonal T cell expansion in association with clonal B cell expansion, 33 and therefore, an oligoclonal T lymphocyte repertoire may be a second explanation for the restricted B cell repertoire post BMT that we present in this study.
A restricted T cell repertoire should, however, not influence the repertoire of newly developed B cells since T cells, as far as we know, do not have a function during B lymphocyte differentiation in the BM. If the limitation in the VH3 repertoire that we show is a reflection of an oligoclonal preimmune repertoire the naive B cells must have acquired this property due to a disturbance of B cell development itself rather than it being an effect of T-B cell interactions. It would therefore be of great interest to investigate the clonal status of the immature B cell compartment in BM from transplant recipients.
A fourth explanation for the oligoclonal appearance of the B cell repertoire could be selection by exogenous antigens. There is some evidence for this since homogeneous Ig components (H-Ig) specific for tetanus toxoid (TT) have been identified in sera from BMT patients after transplantation. However, this finding was only made in a limited number of patients after vaccination with TT and in the majority of the subjects it was not possible to find any HIg reactivity to the panel of antigens tested. 34 Both patients in our present study developed cGVHD. The presence of cGVHD enhances the degree of both in vivo and in vitro B cell immunodeficiency in BMT patients. 2 Development of both aGVHD and cGVHD correlates with a higher incidence of H-Ig components in patient sera. 35 Regarding the functional consequences of a restricted Ig repertoire it is possible that the VH3 containing B cell repertoire that we analyzed is biased towards Ig secreting cells, since plasma cells have up to 100 times higher mRNA content than naive resting B cells. 36 However, we previously showed a restriction of the Ig repertoire on DNA level for the VH6 family, 22 and it is therefore not likely that the oligoclonal nature of the B cell repertoire post BMT is limited to the plasma cell population. The presence of oligoclonality in the plasma cell compartment implicates an effect on the circulating Ig repertoire. Indeed, H-Ig are found in sera from BMT recipients from as early as 3 weeks after BMT up to several years post transplantation. 35, 37 H-Ig of both recipient and donor origin has been demonstrated, even though the H-Ig of donor origin predominates. 37, 38 Taken together, we conclude that the Ig repertoire is oligoclonal during reconstitution after BMT, irrespective of VH gene family usage. In addition, the results demonstrate that different CDR3 regions dominate at different timepoints. We find it most likely that both naive and activated B lymphocytes as well as plasma cells in the circulation share this property. The oligoclonal Ig repertoire may accordingly explain part of the impaired humoral immunity in BMT patients.
